Pyramid Biosciences, Inc. (www.pyramidbio.com), a Boston-based biotechnology company developing new therapies focused on the modulation of cell surface receptors…
read moreSean Ainsworth hopes to strike biotech gold, again, joining Seattle-based Immusoft Corp. as CEO and chairman. Read more >>
read moreGradifi now has more than 300 corporate clients, up from 50 in 2016, when it was bought by First…
read more“It’s the way many millennial parents shop now. We want to access the expensive products without having to spend…
read moreSPEX, the new division of eSight Corporation, has announced that it is introduction its first augmented reality (AR) headset…
read moreGreen Piñata: This educational toy club ships boxes of playthings selected from a catalog organized by curriculum. Read more…
read moreIngredients obtained by KnipBio from specialised strains of leaf symbiont bacteria have been demonstrated to offer promising alternatives to…
read moreThe MedCity INVEST conference brings together investors and executives from healthcare organizations with promising startups in the biopharma, diagnostics,…
read morePittsburgh biotech company CytoAgents has received $250,000 from the Richard King Mellon Foundation to help develop its drug candidate…
read moreKalion Inc., along with 8 other companies, was selected by the U.S. Department of Energy to receive $5.7 million…
read more